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Introduction
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Los Angeles, California
Elucidation of reperfusion phenomena has taken on a new
significance because of the recent clinical developments em-
phasizing prompt restoration of ~erfusion for the protection
and salvage of jeopardized myocardium during acute myo-
cardial ischemia or evolving infarction. Among the striking
new reperfusion approaches are the emergency treatment of
coronary occlusions by intracoronary or intravenous admin-
istration of thrombolytic agents, acute coronary bypass sur-
gery, percutaneous transluminal coronary angioplasty, re-
lease of angiospasm by pharmacologic agents and coronary
venous delivery of oxygenated blood by synchronized hy-
pothermic retroperfusion.
The last decade of rapid transition and innovative de-
velopment has seen a reexamination of established concepts
of myocardial ischemia and reperfusion, along with con-
sideration of newly recognized problems. Thus, prior em-
phasis on lowering of oxygen demands through ventricular
unloading has given way to methods capable of effectively
resupplying oxygen to the acutely ischemic myocardium.
Mechanisms of partial or total coronary obstruction are being
reexamined in relation to platelet deposition, spasm and
coronary thrombosis in an effort to determine the dynamics
of the processes that could lead to acute ischemia and in-
farction. Yet, even when promptly treated with drugs or
reperfusion, mechanical, electrophysiologic or metabolic
function of an ischemic zone may not be fully restored for
weeks. Because of persisting derangements during the early
reperfusion period, the latter should be considered poten-
tially hazardous, requiring continued careful monitoring and
extended conservative management. Some investigators have
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even questioned the benefits of an eventual partial or patchy
myocardial salvage, which could be more apparent than real
if it was associated with arrhythmogenicity, chronic isch-
emia, infarct expansion or extension (1,2). At present, there
is no assurance that current understanding of reperfusion is
adequate to resolve all questions, and further studies will
surely be needed to test the newer concepts.
As part of this reexamination, the current symposium
begins in this issue of lACC with surveys of selected basic
pathophysiologic questions about reperfusion, and includes
specific experimental contributions. The symposium will
continue in next month's issue with clinical reviews and
studies providing an update on recent reperfusion
developments.
Consequences of Reperfusion
Evidence that sudden restoration of coronary blood flow
may result in serious structural and functional derange-
ments, even when instituted as early as 1 hour after an acute
coronary occlusion in dogs, was already demonstrated in
our 1975 symposium on reperfusion (3), and has been cor-
roborated in numerous publications (4-7). Thus, restoration
of epicardial coronary artery flow after 3 hour proximal
occlusion in closed chest dogs failed to salvage the acutely
ischemic myocardium in about one-third of the animals,
even though there still was, on the average, a significant
reduction in infarct size (8). Furthermore, such reperfusion
of the jeopardized tissue was generally associated with a
substantially delayed return of function (metabolic, con-
tractile and electrophysiologic), although myocardial via-
bility and eventual survival could be demonstrated (9).
The potentially serious ultrastructural and functional der-
angements could be attributed to a "no reflow" phenomenon
characterized by cell swelling, tissue edema, cellular cal-
cium influx and washout of accumulated metabolites and
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electrolytes. When accentuated, these reperfusion effects
lead to structural changes and irreversible myocardial dam-
age marked by explosive cell swelling and mitochondrial
calcium phosphate accumulations (10, II).
Effects of the Ischemic Process
on Reperfusion
It is important to note that evolving or intermittent myo-
cardial ischemia and partial or full restoration of myocardial
perfusion may be viewed as interdependent dynamic pro-
cesses that occur in many settings of ischemic heart disease.
Clearly, the severity of myocardial injury associated with
an ischemic syndrome will depend most importantly on the
grade and persistence of the perfusion defect and on de-
mands imposed on the regionally ischemic myocardium by
the prevailing physiologic state. Single or repeated reper-
fusion superimposed on an ischemic injury could exacerbate
the progressive damage. Such a process may apply in severe
stenosis of a major coronary artery or intermittent coronary
obstructions by angiospasm, and could be a precursor of
thrombotic coronary artery occlusion evolving into myo-
cardial infarction (12).
Reversible versus irreversible ischemia. Reperfusion
would be expected to follow a very different path when
applied to potentially reversible versus irreversible ischemic
injured myocardium. In severe but still reversible myo-
cardial ischemia, such as has been described in the earliest
stage after an acute coronary occlusion, the ultrastructural
changes include a rapid loss of glycogen, the development
of apparent intracellular edema and mitochondrial swelling
and pyknosis (9,13). Contractile activity is rapidly lost within
several beats and creatine phosphate as well as adenosine
triphosphate and creatine phosphate reserves decrease as
glycolysis and anaerobic metabolism develop in the absence
of sufficient coronary collateral circulation. With total de-
cline in glycogen, sharply diminished circulation and in-
creasing cytoplasmic concentrations of protons, dihydro-
nicotinamide adenine dinucleotide and lactate, the
myocardium is unable to provide for basal cellular energy
requirements and the limits of viability are reached.
The fully reversible ischemic period has been estimated
in the dog's posterior papillary muscle or free wall suben-
docardium as 20 to 40 minutes after an acute coronary
occlusion. Near transmural necrosis has been generally re-
ported in dog myocardium anywhere from 4 to 6 hours
postocclusion, after an endocardial to epicardial "necrotic
wave propagation" (14). Therefore, to save cardiac tissue
before it becomes irrevocably destined to die, reperfusion
must be started before the onset of significant irreversible
injury, or ischemia must be treated before reperfusion to
prevent or delay the critical transition from reversible to
irreversible states. Although one would wish to generalize
in terms of a critical period of survival, no such universal
criterion is possible in the presence of variable amounts of
compensatory coronary collateral blood supply.
Delayed return of function after reperfusion. As pre-
viously mentioned, reperfusion of acutely ischemic but re-
versibly injured myocardium can be associated with a most
significant and potentially dangerous delay in the return of
function. This period of stunned or obtunded function after
reperfusion may last for weeks when reperfusing after only
20 minutes to I hour of acute coronary occlusion, with the
eventual outcome uncertain in view of a possible extension
of damage (7). The effects of reperfusion are probably more
complex when, as is often the case, one deals with com-
binations of regionally reversible and irreversible ischemic
injury. Mixed or patchy salvage by reperfusion, or else
through coronary collateral supply, would be reflected in
varying improvements in regional ventricular function. The
latter is also influenced by mechanical tethering of adjoining
segments, changes in myocardial stiffness due to edema,
derangement caused by arrhythmias and abnormal metab-
olism after reperfusion. Prolonged dysfunction of injured
ischemic zones could, in the absence of effective treatment,
lead to serious global consequences, such as hypotension
or shock, and further ischemia and infarction (15-17). Col-
lateral circulation may, of course, develop gradually over
a period of hours or days whenever there are adequate an-
atomically preexisting coronary collateral channels.
It is necessary to evaluate the true effectiveness of re-
perfusion for as long as several weeks after its initiation to
clearly establish resumption of normal myocardial perfusion
and regional as well as global cardiac function (7,9). This
suggests that early stress testing and intensive rehabilitation
during the obtunded postreperfusion state could precipitate
more damage and should be delayed until adequate and
stable cardiac function is reestablished. Early reperfusion
phenomena may also affect the outcome of coronary bypass
surgery, during which apparently reversibly ischemic myo-
cardium undergoes a perioperative infarction in about 5 to
10% of candidates, despite the fact that in 70% of those
examined the bypass grafts remained patent (18). The in-
cidence, cause and mechanisms of this damage are still being
debated but they could be due to reperfusion derangements
of ischemia that may be minimized by treatment such as
gradual reperfusion (19) or retroperfusion of the coronary
sinus (20).
Irreversible ischemic injury. Beyond the point when
major irreversible ischemic injury has ensued, reperfusion
might not be effective at all; in fact it may even cause a
major extension of myocardial damage. However, it is often
unclear to what degree the eventual outcome was inevitable
in view of the extent and character of acute ischemic injury
just before reperfusion. Thus, necrosis of myocardium after
an acute coronary occlusion is followed in time by irrever-
sible damage to its microvasculature, so that sudden reper-
fusion at normal rate and pressure may rupture intramural
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microvessel walls with consequent myocardial hemorrhages
and augmented interstitial edema. Irreversible acute isch-
emic injury is also most often associated with substantial
metabolite accumulations, which in themselves, are re-
sponsible for accelerated vicious cycles of ischemic damage
and necrosis. The rapid and major washout of metabolites,
enzymes and electrolytes during reflow has been recognized
as a likely cause for some of the harmful consequences of
reperfusion, such as the development of hazardous arrhyth-
mias. Washout of adenonine, hypoxanthine and inosine ap-
parently precludes rapid resynthesis of ATP, whereas a sud-
den cell reflow with calcium may be related to persisting
contractile derangements. Moreover, until it is resorbed,
edema could limit the extent of contractile recovery.
Severe postreperfusion edema, characterized through
measurements of significantly increased tissue wall thick-
ness (by two-dimensional echocardiography), has recently
been correlated with the extent of eventual myocardial ne-
crosis (21). Such early postreperfusion wall thickness mea-
surements could be used clinically to predict myocardial
viability or infarction. However, questions about reflow
impedance through regional tissue swelling and its effect
on eventual postreperfusion salvage or residual derange-
ments are yet to be fully explored. Another effect involves
significant temporary derangements of contractile and met-
abolic function in zones adjacent to, and even remote from,
a regional irreversible acute ischemic injury. These remote
derangements can add to global dysfunction and potentially
limit recovery after reperfusion (22).
Current Developments in the Field
of Reperfusion
Ultrastructural correlates of ischemic injury. In their
contribution to this symposium, Schaper and Schaper (23)
review ultrastructural correlates of ischemic injury after
coronary occlusions of various durations, as well as the
subsequent and consequent changes noted during reperfu-
sion followed up to 48 hours. As anticipated, the cellular
degradation depended on the duration and degree of isch-
emic injury before reperfusion, with eventual necrosis ex-
tending from the subendocardial layer for brief occlusion to
the subepicardium for longer periods of coronary occlusion.
Reperfusion produced only limited alterations in the pres-
ence of slight ischemia, in contrast to marked structural
deterioration of irreversibly injured myocardium. In re-
versible ischemic injury, extended reperfusion appears to
be characterized by lysozomal enzyme activity "scaveng-
ing" intracellular debris, and structural reorganization that
contributes to recovery of injured myocytes. In contrast,
irreversibly damaged myocyte lysozomes do not contribute
to autophagocytosis. The investigators also examine the ac-
curacy of postreperfusion measurements of myocardial ne-
crosis using tetrazolium-type substances. Although they
conclude that the histochemical methodology is generally
adequate, they do not rule out that reperfusion may accel-
erate destruction of ischemic tissue that is already very close
to the "point of no return."
Functional and biochemical improvement during re-
perfusion. Ellis et al. (24) followed up dogs for 2 weeks
of reperfusion, after 2 hours coronary occlusion and com-
pared measurements of cardiac function and adenosine tri-
phosphate, as well as creatine phosphate with similar mea-
surements in nonreperfused control dogs (with 2 weeks of
maintained occlusion). In their model, 2 hours of occlusion
with 4 hours of reperfusion led to a 24% largely subendo-
cardial necrosis, compared with 89% essentially transmural
necrosis after 6 hours of permanent occlusion. Two-dimen-
sional echographic study revealed thinning in the acutely
ischemic region and failure of the central portion of the
ischemic zone to develop active wall thickening in the first
72 hours of reperfusion. Yet, a significant partial return to
approximately 20% thickening was found 14 days after re-
perfusion (compared with 48% in preocclusion control), in
contrast to persisting regional thinning in permanently oc-
cluded dogs. It required a period of 7 days for recovery of
ATP levels in salvaged reperfused zones to near preocclu-
sion levels. Both functional and biochemical recovery dur-
ing reperfusion was achieved only after significant delay.
Incidence and treatment of reperfusion arrhythmias.
Reperfusion-induced arrhythmias and ventricular fibrillation
have been studied often, but their mechanisms and optimal
treatment remain unclear. Thandroyan et al. (25) describe
alpha- and beta-adrenoceptor antagonist effects on ischemic
myocardial metabolism and incidence of ventricular fibril-
lation. Prazosin and phentolamine given before coronary
artery occlusion protected against reperfusion ventricular
fibrillation, whereas previous reserpinization failed. The
alpha-antagonist, yohimbine, was found to have antiar-
rhythmic potential and dl-propranolol and metoprolol were
also effective, but atenolol had no effect. The investigators
noted that membrane-stabilizing activity rather than receptor
antagonism explains the apparent prevention of postreper-
fusion fibrillation by beta-adrenoceptor antagonists. Isch-
emic tissue metabolism could not be clearly associated with
reperfusion arrhythmias, in spite of indications from pre-
vious studies (26).
Coronary venous retroperfusion. To treat the acutely
ischemic and essentially inaccessible myocardium beyond
a coronary occlusion and thus prevent hazardous early re-
perfusion derangements, Haendchen et al. (20) applied mod-
erately hypothermic coronary venous synchronized retro-
perfusion in closed chest dogs because it has been shown
to extend viability and function of reversibly injured isch-
emic myocardium. Untreated 3 hour coronary occlusion
followed by 7 days reperfusion was compared with retro-
perfusion treatment from 30 minutes to 3 hours occlusion
followed by 7 days of reperfusion. Two-dimensional echo-
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cardiography was employed to map ischemic and non-
ischemic segmental function, and the extent of myocardial
necrosis was delineated by triphenyl-tetrazolium-chloride.
The retroperfusion treatment decreased mortality and mean
infarct size, significantly enhanced global as well as isch-
emic segmental function during the coronary occlusion and
minimized early and later reperfusion derangements. Further
study is needed to test the effectiveness of this form of
treatment, with longer periods of coronary occlusion and
more extended durations of retroperfusion.
Surgical revascularization in evolving myocardial in-
farction. This symposium will be continued in the next
issue of lACC, with emphasis on the clinical aspects of
reperfusion. DeWood et al. (27) will reevaluate comparative
results of early (within a mean of 4.8 hours from symptom
onset) versus late (mean 9.2 hours) surgical revasculariza-
tion in evolving acute anterior transmural myocardial in-
farction. Two-dimensional echographic study of contraction
demonstrated that the early revascularization was signifi-
cantly more effective in recovery of segmental function after
reperfusion. Quoting indications that such surgical reper-
fusion can be performed with low mortality (2 to 5%), the
authors urge that the revascularization be performed as early
as possible in the course of an evolving myocardial infarc-
tion, and point to a need for better markers of tissue salvage.
Myocardial preservation during bypass surgery. Ro-
senkranz and Buckberg (28) review newly modified myo-
cardial protection and preservation during coronary bypass
surgery for safety, simplicity and optimal effectiveness. In
particular, myocardial cooling and control of reperfusate
blood composition were optimized to almost completely
avoid the metabolic and functional consequences of hy-
pothermic cardioplegic ischemic cardiac arrest, specifically
by modifying the temperature, pressure and ionic content
of blood reperfusate during the first 5 minutes of reoxy-
genation. The authors describe a combined intervention that
allows up to 4 hours of safe aortic clamping with cold blood
cardioplegia and returns cardiac metabolism and ventricular
compliance to control levels. This was achieved by: 1) che-
lation to decrease available ionic calcium; 2) the correcting
alkalosis of reperfusate; 3) maintenance of temporary car-
dioplegia during reperfusion; 4) maintenance of hyperos-
molarity and lower perfusion pressure to minimize edema;
and 5) warming of the reperfusate.
Intracoronary thrombolysis during evolving infarc-
tion. Experience with intracoronary thrombolysis is re-
viewed by Ganz et al. (29), who provided some recent data
on lytic treatment of an evolving myocardial infarction within
its early stage (up to 3 hours). An important point is that
such a nonsurgical reperfusion technique can be effective
and relatively safe, but only if the treatment is instituted
very early after the initial symptoms. Myocardial salvage
was reported by the authors using a new intracoronary thal-
lium imaging method, and functional improvements after
the reperfusion were measured with two-dimensional
echocardiography. The authors also review suggestive evi-
dence of reduced mortality through early reperfusion, but
these are not randomized studies. Coronary reocclusion phe-
nomena are discussed and the importance of appropriate
continuing anticoagulation emphasized.
Intravenous versus intracoronary thrombolytic re-
perfusion. Thrombolyticreperfusion is discussed by Schroder
(30), who compared the newest intravenous administration
versus intracoronary artery treatment. In 50 patients with
up to 13 weeks follow-up, a high dose (500,000 to 1,050,000
IV) intravenous infusion carried out over a period of 30 to
60 minutes resulted in an 84% reperfusion success rate,
verified by creatine kinase-MB enzyme analysis and coro-
nary angiography in the fourth week. This compared with
a 25% demonstrated spontaneous clot lysis within 8 weeks
in an equivalent control group of 52 patients without strep-
tokinase or heparin treatment. In a total of 69 patients,
streptokinase infusion was begun in 36 within 3 hours after
onset of symptoms, and none exhibited reocclusion. In con-
trast, reinfarction occurred in 6 of 33 patients with later
streptokinase infusion. Schroder (30) considers ultimate clot
lysis equally effective with intravenous and intracoronary
routes. Even though the time to lysis may be considerably
longer (60 to 120 minutes) than with intracoronary appli-
cation, earlier intravenous administration in an emergency
facility may well make up for this difference. The authors
believe that the combination of intravenous and intracoron-
ary streptokinase may increase the successful lysis rate to
more than 90% and they quote a European Cooperative
Group Trial of intravenous streptokinase that suggests sig-
nificant lowering of 6 month mortality and improved left
ventricular function in successfully recanalized patients.
Coronary venous retroinfusion of streptokinase. A
variant of streptokinase thrombolysis was explored exper-
imentally by Meerbaum et al. (31). In closed chest dogs
with an induced proximal coronary artery thrombus, ret-
rograde regional coronary venous infusion of streptokinase
at a low rate of less than 2,000 IV/min resulted in lysis
within a mean of 50 minutes. An equivalent dosage of
streptokinase administered systemically also led to lysis but
significantly later, in an average of 132 minutes. Although
the significance and limitation of this new method remain
to be assessed, it is interesting to note that this retrograde
thrombolytic technique can be combined with synchronized
coronary venous retroperfusion treatment to protect the jeop-
ardized ischemic myocardium while awaiting effective re-
perfusion by lysing of the thrombus. The retroperfusion
method was readily applied, promptly improved contractile
function of ischemic cardiac regions in dogs and signifi-
cantly extended viability of jeopardized myocardium.
Coronary angioplasty. Williams et al. (32) discuss per-
cutaneous transluminal coronary angioplasty (PTCA), which
may bear some relation to reperfusion, because its aim is a
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significant and prompt enhancement of myocardial perfu-
sion. Severe coronary stenosis often depletes flow reserve
capacity and coronary angioplasty clearly improved this ca-
pacity. Alpha-adrenergic tone withdrawal in normal patients
is responsible for increased coronary flow under stress,
whereas patients with coronary artery disease fail to show
this response. After successful angioplasty coronary flow is
again increased during stress, suggesting restoration of nor-
mal alpha tone. Williams et al. (32) report no arrhythmias
because of the angioplasty-induced increased perfusion.
Longer term studies are required to characterize the rate at
which segmental myocardial function returns with angio-
plasty and to elucidate incidence and mechanisms of even-
tual angioplasty failures (31 of95 in the reported study [32]).
Current Perspective on Reperfusion Issues
We now recapitulate what seems to us is the current state
of the understanding of reperfusion. Reperfusion derange-
ments should be viewed against the background of the mode,
extent and severity of the myocardial ischemic injury before
reperfusion. Certainly, as coronary stenosis differs from full
coronary artery occlusion , effects of a temporary or inter-
mittent ischemia from continuous ischemia , while vaso-
spasm appears distinct from platelet deposition or intracor-
onary thrombosis. As discussed , the consequences of re-
perfusion will be more extensive and indeed permanent when
applied after irreversible ischemic injury. Nonetheless , it is
important to be aware of the potential effects of reperfusion
and to expand our understanding beyond attempts to gen-
eralize it as a "3 to 4 hour critical period" of coronary
occlusion beyond which reperfusion may not be beneficial.
In fact, this period will differ from patient to patient and
depends on many factors, including the size of the ischemic
involvement , extraneous cardiac demands and compensa-
tory coronarycollateralsupply to thejeopardizedmyocardium.
It would seem that we are still unable to fully explain
the underlying causes and mechanisms of reperfusion ar-
rhythmias, although they may well be related to rapid elec-
trolyte washout and can be decreased through gradual re-
perfusion . Reperfusion-induced hemorrhages have been the
focus of several recent studies (33,34), and some satisfaction
was derived from the fact that the hemorrhages are generally
included within the irreversibly damaged cardiac tissue. Yet,
hemorrhage exacerbates tissue swelling which results in ob-
tunded myocardium and functional derangements, which,
in tum , are related to the size of the eventually developed
infarction . The " lagging return of mechanical or metabolic
function," even when reperfusion involves reversibly in-
jured myocardium, has been highlighted and we may expect
more clarification of mechanisms , implications and treat-
ment. We believe that the ultrastructural and functional end
points of reperfusion effectiveness deserve further study,
because it is absolutelyessential to ascertain weeks or months
after the reperfusion if salvage is complete and permanent,
or if the reperfused zones may be the seat of further chronic
ischemia and arrhythmogenicity.
Equally important , throughout the early and subsequent
period of reperfusion, it is necessary to have an accurate
picture of alterations in myocardial contraction and perfu-
sion. Repeated coronary angiography is, of course, quite
valuable but must be limited from a practical standpoint.
We find that the new computerized imaging techniques of
contrast enhanced digital angiography, thallium and tech-
netium methodologies and computerized myocardial con-
trast two-dimensional echocardiography will provide quan-
titative data on the extent of regional and global function
and dysfunction. They will reveal, in particular, the spon-
taneous or treated course of contraction, chamber volume
phasic wall thickness and thinning plus perfusion in both
ischemic reperfused and normal zones of the heart (20,21).
These measurements should prove to be valuable supple-
ments of prevalent electrocardiographic and cardiac enzyme
methods that have been of limited value in the quantitative
assessment of reperfusion. It is important to provide prompt ,
long-term accurate monitoring to provide documented evi-
dence of the therapeutic effectivenes s of measures which
protect jeopardized myocardium during the crucial acute
stages of ischemia and reperfusion .
It is satisfying to note the substantial success of new
techniques such as thrombolysis and percutaneous translu-
minal coronary angioplasty; however , caution is indicated
until the longer term effects and results can be correctly
assessed. We believe that problems such as the severe post-
reperfusion derangements and perioperative infarction after
acute coronary occlusions or revascularization indicate a
need for further study of reperfusion mechanisms. Improved
models are also needed to investigate incomplete or gradual
rather than total and suddenly applied reperfusion, because
the mode of reperfusion would influence the derangements
caused by rapid washout, calcium overloading , myocardial
edema, microvascular damage and hemorrhages (19). Fi-
nally and fundamentally, reperfusion must be applied as
early as possible, while much of the myocardium is viable
and injury is still reversible. Wherever possible, irreversible
myocardial damage must be avoided and viability main-
tained through treatment promptly delivered to the most
severely jeopardized region. This treatment should be started
very early after the initial acute ischemic event and carried
through the early and unstable reperfusion period until ef-
fective restoration of perfusion, contraction , metabolism and
electrophysiologic function is achieved.
An optimal treatment cannot be specifiedas yet and would
depend on many considerations, such as the nature and
extent of ischemic injury. However, retrograde coronary
venous delivery of arterial blood and hypothermia to the
jeopardized region is promising and may provide the desired
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support before and after coronary reperfusion (20). Caution
should be exercised to minimize physical stress and myo-
cardial demands during the critical period after reperfusion,
which may extend up to several weeks and during which
function may slowly recuperate. We believe that an excel-
lent opportunity now exists for rational application of re-
perfusion, along with appropriate and essential monitoring
utilizing modem cardiac imaging techniques.
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